Csenge Advisory Group Albemarle Corp Transaction History

Csenge Advisory Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$108.73 - $146.89 $218,764 - $295,542	2,012 New	2,012 $265,000
Q2 2023 Jul 20, 2023	BUY	$172.91 - $232.22 $166,166 - $223,163	961 New	961 $214,000
Q3 2022 Oct 04, 2022	BUY	$195.82 - $307.05 $150,193 - $235,507	767 New	767 $203,000
Q4 2018 Feb 07, 2019	SELL	$73.13 - $107.99 $1,755 - $2,591	-24 Closed	0 $0
Q3 2018 Nov 19, 2018	BUY	$90.9 - $106.6 $2,181 - $2,558	24 New	24 $2,000

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $6.72B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

Stay updated on Csenge Advisory Group with notifications on news.